H1 Blog

Helpful hints for MSLs
Maria Amorosso
|
Jan 5
H1 Closes $58 Million Series B Funding
Ariel Katz
|
Dec 17
SURVEY // COVID-19, Scientific Exchange with KOLs and the Future Impact on the MSLs
Josh Pirtle
|
Nov 12
Market share: Answer strategic questions by mapping patient referral behavior
Josh Pirtle
|
Nov 12
The New Normal
Robert Consalvo
|
Nov 6
Episode 2: Navigating the Impact of COVID-19 to Ensure a Successful Product Launch Through the Effective Utilization of Medical Affairs and MSLs
Josh Pirtle
|
Nov 12
Referral Networks: Identify the Regional Leaders Who are Seeing the Most Patients Related to a Certain Diagnosis.
Josh Pirtle
|
Nov 12
Patient Journey: Track the Sequence of Care from Point of Access into the Health System to Outpatient Care.
Josh Pirtle
|
Nov 12
Payor Type: Understanding How Patients Receive Care and Who Pays for it
Josh Pirtle
|
Nov 12
Episode 1: COVID-19, Scientific Exchange with KOLs and the Future Impact of MSLs
Josh Pirtle
|
Nov 12
How KOLs prefer to engage with MSLs during the COVID-19 pandemic: Survey
Josh Pirtle
|
Nov 12
Scientific Communication
Josh Pirtle
|
Sep 17
How H1 Technology and Data Support Clinical Research
Josh Pirtle
|
Nov 12
Insights into Sleep Medicine
Josh Pirtle
|
Sep 17
Insights Into Psychology
Josh Pirtle
|
Sep 17
Dr. Eric Peterson's Impact in Cardiology
Josh Pirtle
|
Sep 17
Dr. Emily Mackler's Impact on Oncology
Josh Pirtle
|
Sep 17
Oncology Insights
Josh Pirtle
|
Sep 17
Dr. Daniel Sessler's Impact on Anesthesiology
Josh Pirtle
|
Sep 17
5 Thought Leaders from the ASCO 2020 Meetings You Should Know
Josh Pirtle
|
Sep 17
Coronavirus Insights
Josh Pirtle
|
Sep 17
Rheumatology Insights
Josh Pirtle
|
Sep 17
Dr. David T Felson's Impact in Rheumatology
Josh Pirtle
|
Sep 17
Allergy & Immunology Insights
Josh Pirtle
|
Sep 17
Dr. Amal H Assa'ad impact in Allergy & Immunology
Josh Pirtle
|
Sep 17
Hematology Insights
Josh Pirtle
|
Sep 17
Dr. Hagop M. Kantarjian, M.D. impact on Hematology
Josh Pirtle
|
Sep 17
H1 is Updating its Brand to Reflect its Larger Vision in Healthcare
Josh Pirtle
|
Sep 17
H1 Providing Free Access to HCPs
Josh Pirtle
|
Sep 17
The Impact of Dr. Adnan Majid work in Pulmonary Disease
Josh Pirtle
|
Sep 17
Susan Weiss - USA Leader in Coronavirus
Josh Pirtle
|
Sep 17
Stanley Marc Perlman - USA Leader in Coronavirus
Josh Pirtle
|
Sep 17
Ralph Baric - USA Leader in Coronavirus
Josh Pirtle
|
Sep 17
H1: Announcing A New Way to Identify KOLs with Procedure and Diagnosis Medical Claims Data
Josh Pirtle
|
Jan 13
Your CRM at Maximum Strength: Powered by H1
Josh Pirtle
|
Sep 17
What Big Data Means for Medical Affairs
Josh Pirtle
|
Sep 17
Dr. Jason McLellan’s Coronavirus Breakthrough
Josh Pirtle
|
Sep 17
Pain Management Insights
Josh Pirtle
|
Sep 17
Dr. Yi Zhang Impact on Anesthesiology and Pain Management
Josh Pirtle
|
Sep 17
Gastroenterology Insights
Josh Pirtle
|
Sep 17
The Impact of Gastroenterologist Dr. Ramnik Xavier
Josh Pirtle
|
Sep 17
Dermatology Insights
Josh Pirtle
|
Sep 17
Dr. Jun Lu's Impact on Dermatology
Josh Pirtle
|
Sep 17
Cardiology Insights
Josh Pirtle
|
Sep 17
Cardiology Leader Dr. Deepak L. Bhatt
Josh Pirtle
|
Sep 17
Anesthesiology Insights
Josh Pirtle
|
Sep 23
The Impact of Anesthesiologist Dr. Miles Berger
Josh Pirtle
|
Sep 17
H1. Launches Bi-Directional Influence for all Global HCPs
Josh Pirtle
|
Sep 17
Five Important Ways Millennial Patients Are Different
Josh Pirtle
|
Sep 17
Engaging Millennial Healthcare Providers
Josh Pirtle
|
Sep 17
5 Daily Challenges of MSLs
Josh Pirtle
|
Sep 17
The Many Responsibilities of Medical Science Liaisons
Josh Pirtle
|
Sep 17
The Future of Medical Affairs
Josh Pirtle
|
Sep 17
The Importance of COLs and DOLs
Ariel Katz
|
Sep 17
Trends In Oncology: Medical Science Liaisons
Josh Pirtle
|
Sep 17
The Typical Medical Science Liaison
Josh Pirtle
|
Sep 17
A Rare Species: The Medical Device KOL
Josh Pirtle
|
Sep 17
Real World Evidence – Here to Stay
Josh Pirtle
|
Sep 17
Clinical Trial Educators - Addressing Challenges in Patient Recruitment for Clinical Trials
Ariel Katz
|
Sep 17
Health Outcomes Liaison – Managing Relationships with Payers
Ariel Katz
|
Sep 17
New Ways of Engaging Healthcare Providers
Josh Pirtle
|
Sep 17
Medical Science Liaisons in the Age of Personalized Medicine – Part 1
Josh Pirtle
|
Sep 17
Five Ways That Artificial Intelligence Will Benefit Medical Science Liaisons
Ariel Katz
|
Sep 17
Patient Opinion Leaders – How Much Transparency Do We Need?
Ariel Katz
|
Sep 17
Patient Opinion Leader – Patients Shaping Healthcare Decisions
Ariel Katz
|
Sep 17
MSL Conduct Dos and Don'ts
Ariel Katz
|
Sep 17
Which Types of Skills Are Most Valuable to MSLs
Ariel Katz
|
Sep 17
Improving Technology Improves the Lives of MSLs
Ariel Katz
|
Sep 17
Complying with MSL Regulations
Ariel Katz
|
Sep 17
H1 At The New York Health Forum Panel
Ariel Katz
|
Sep 17
H1 Honored as One of the Most Innovative Startups of 2018
Ariel Katz
|
Sep 17
MSL Guide to Using White Papers
Ariel Katz
|
Sep 17
Changing Methods of Communicating With Healthcare Providers
Ariel Katz
|
Sep 17
Engaging KOLs Overseas
Ariel Katz
|
Sep 17
Changing Communication Methods in Pharma
Ariel Katz
|
Sep 17
The Importance of KOLs
Ariel Katz
|
Sep 17
KOL Presentations Go Digital
Ariel Katz
|
Sep 17
The Roles of KOLs Throughout the Drug Development Process
Ariel Katz
|
Sep 17
Opinion Leader Identification: Big Data to KOL Short List
Ariel Katz
|
Sep 17
GSK Brings Back Payments to KOLs
Ariel Katz
|
Sep 17
Extending the Sunshine Act of 2018
Ariel Katz
|
Sep 17
Episode One: H1. Doctors in the Data Podcast with Dr. Raj
Ariel Katz
|
Sep 17
Finding KOLs – Identifying the Right Expert in a Sea of Possibilities
Ariel Katz
|
Sep 17
The Science and Hard Work of Building and Maintaining a KOL Database
Ariel Katz
|
Sep 17
Not the Typical Opinion Leaders
Ariel Katz
|
Sep 17
Clinical Trial Liaisons to the Rescue
Ariel Katz
|
Sep 17
Part 4: How to Measure Influence? The Challenge of Establishing Performance Review for Medical Science Liaisons
Ariel Katz
|
Sep 17
Part 3: Changes in the Pharma Industry Affect the Jobs of Medical Science Liaisons
Ariel Katz
|
Sep 17
Part 2: Trends that shape the Role of Medical Science Liaisons
Ariel Katz
|
Sep 17
Challenging The Status Quo: What Charles Darwin Means to H1
Ariel Katz
|
Sep 17
Part 1: A Day in the Life of a Medical Science Liaison
Ariel Katz
|
Sep 17
An H1 'Insight': The Importance of Using Open Payment Data
Ariel Katz
|
Sep 17
Intellectual Curiosity: What Ada Lovelace Means to H1
Ariel Katz
|
Sep 17
Innovation: What Marie Curie Means to H1
Ariel Katz
|
Sep 17
An H1 ‘Insight’: Trends Shaping the Future of Medical Affairs: Part 2
Ariel Katz
|
Sep 23
An H1 'Insight': The Changing Role of Medical Affairs
Ariel Katz
|
Sep 17
Keep Your Customers Close - and Your KOLs Closer
Ariel Katz
|
Sep 17
The Story Behind the Name H1
Ariel Katz
|
Sep 17
What’s in a name: should we continue to use the term “KOL?”
Ariel Katz
|
Sep 17
Connecting the world of healthcare
Copyright © 2020
About UsBlog
ContactCareers
Privacy PolicyTerms of Service
LinkedInTwitterPress